KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Other Non-Current Assets (2016 - 2025)

Neogenomics' Other Non-Current Assets history spans 15 years, with the latest figure at $9.4 million for Q4 2025.

  • For Q4 2025, Other Non-Current Assets rose 59.6% year-over-year to $9.4 million; the TTM value through Dec 2025 reached $9.4 million, up 59.6%, while the annual FY2025 figure was $9.4 million, 59.6% up from the prior year.
  • Other Non-Current Assets reached $9.4 million in Q4 2025 per NEO's latest filing, up from $8.2 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $9.4 million in Q4 2025 to a low of $4.1 million in Q2 2024.
  • Average Other Non-Current Assets over 5 years is $6.0 million, with a median of $5.7 million recorded in 2024.
  • Peak YoY movement for Other Non-Current Assets: plummeted 88.61% in 2021, then surged 74.9% in 2025.
  • A 5-year view of Other Non-Current Assets shows it stood at $7.2 million in 2021, then fell by 28.72% to $5.1 million in 2022, then fell by 7.18% to $4.7 million in 2023, then rose by 24.12% to $5.9 million in 2024, then surged by 59.6% to $9.4 million in 2025.
  • Per Business Quant, the three most recent readings for NEO's Other Non-Current Assets are $9.4 million (Q4 2025), $8.2 million (Q3 2025), and $7.1 million (Q2 2025).